Publications by authors named "Debasish Basu"

Article Synopsis
  • The study explored the acceptability and feasibility of telemedicine-assisted buprenorphine induction (TABI) for treating opioid use disorder in India.
  • Among the 60 patients enrolled, a high retention rate of 88.3% during the TABI program and 83.3% at the 3-month follow-up was observed.
  • Patient satisfaction was moderate, with 58.3% satisfied, but only 25% would recommend TABI, indicating the need for additional research to enhance its effectiveness and wider implementation.
View Article and Find Full Text PDF
Article Synopsis
  • Cortical differences in thickness, folding, and complexity may indicate changes in synaptic pruning and myelination, particularly in individuals with opioid use disorder (OUD).
  • A study compared 69 males with OUD to 25 non-drug-using controls, finding greater sulcal depth and lower gyrification index in specific brain areas associated with OUD.
  • Early initiation and longer duration of opioid use correlated with significant changes in cortical thickness, suggesting these factors may contribute to structural brain abnormalities.
View Article and Find Full Text PDF

Background And Objectives: Substance use among young college students in India poses public health challenges. This study seeks to uncover the motivation behind alcohol and illicit drug consumption, applying social norms theory.

Methods: This qualitative research utilized the framework method to analyze data from 14 college students (18-24 years) across various disciplines.

View Article and Find Full Text PDF

Background: This study explored the relationship between personality attributes and substance use disorder (SUD). Research has identified specific personality dimensions, such as neuroticism, psychoticism, antisocial personality traits, paranoia, and anxiety, as contributing factors on the way to the initiation, continuation, and relapse of SUD.

Purpose: To explore this connection, we examined the personality profiles of subjects with alcohol use disorder (AUD) and opioid use disorder (OUD).

View Article and Find Full Text PDF

Background: Alcohol misuse is prevalent among college students globally, including in India. Digital screening and brief interventions (DSBI) promise to address this issue. This study assesses DSBI's effectiveness in a state-wide cluster randomized trial among college students in India.

View Article and Find Full Text PDF

Enhancing resilience is one way to prevent future mental illnesses and encourage recovery in the face of adversity. To develop and test the acceptability and feasibility (A&F) of a combined family and individual resilience intervention in two rural/semi-rural low-income settings in India and Kenya. We developed a five-session intervention including Life Skills Education (LSE) and a model of family resiliency.

View Article and Find Full Text PDF

Background: Pregabalin, approved for various medical conditions, has shown increasing misuse potential globally. However, limited research exists on pregabalin dependence in India. This study aimed to investigate the prevalence and characteristics of pregabalin dependence among individuals seeking substance use disorder (SUD) treatment in North India.

View Article and Find Full Text PDF

Background: Understanding pathways to dual diagnosis (DD) care will help organize DD services and facilitate training and referral across healthcare sectors.

Aim: The aim of our study was to characterize the stepwise healthcare and other contacts among patients with DD, compare the characteristics of the first contact persons with common mental disorder (CMD) versus severe mental illness (SMI), and estimate the likelihood of receiving appropriate DD treatment across levels of contacts.

Methods: This cross-sectional, descriptive study in eight Indian centers included newly enrolled patients with DD between April 2022 and February 2023.

View Article and Find Full Text PDF

Background: Substance use disorders (SUDs) are among the leading causes of morbidity in the population. In low- and medium-income countries like India, there is a wide treatment gap for SUD. A multicentric study on the care pathways for SUD in India can help to understand service provision, service utilization, and challenges to improve existing SUD care in India.

View Article and Find Full Text PDF

Background: The COVID-19 pandemic has affected the availability and access to medications for opioid dependence (OD). We examined the monthly trends in new buprenorphine/naloxone (BNX) treatment episodes, number of clinical visits for BNX, BNX dispensed per person, and BNX prescription over 56-month, which included pre-pandemic, during early, and later part of pandemic (Jan 2017 - Aug 2022).

Methods: Research data were collected from the pharmacy database of a large publicly funded treatment center in India.

View Article and Find Full Text PDF

Background: Medications for opioid use disorder (OUD) may influence neurocognitive functions. Inadequate power, confounders, and practice effects limit the validity of the existing research. We examined the change in cognitive functions in patients with OUD at 6-month buprenorphine (naloxone) posttreatment and compared the cognitive performance of the buprenorphine-treated group with control subjects.

View Article and Find Full Text PDF

Cannabis and opioid co-dependence is independently associated with cognitive impairments. We examined neurocognitive dysfunctions in people with concurrent opioid dependence with cannabis dependence (OD+CD) or cannabis use (OD+CU) compared to those with only opioid dependence (OD) and healthy controls (HC). We selected adult participants, any sex, who met the diagnosis of OD ( = 268), OD+CU ( = 58), and OD + CD ( = 115).

View Article and Find Full Text PDF

Background And Objectives: Planning and implementing prison-based substance use disorder (SUD) interventions are challenging. We wanted to understand why and how people in correctional settings (CS) use drugs and to explore what policies, environmental, and interpersonal factors influence substance use among incarcerated people. Using the Behavior Change Wheel (BCW) framework, we proposed a thematic map with intervention functions to reduce substance use in CS.

View Article and Find Full Text PDF
Article Synopsis
  • There is a potential link between immune function and cognition in schizophrenia, but this study aimed to explore the same relationship in patients with Acute and Transient Psychotic Disorders (ATPDs), an illness similar to schizophrenia.
  • Researchers analyzed a group of 19 ATPD patients during their acute phase and again after remission, comparing their cognitive performance using the Montreal Cognitive Assessment Scale (MoCA) to individuals with schizophrenia in remission.
  • Results showed that ATPD patients had notable cognitive deficits during both phases of their illness, but no significant connection was found between immune marker levels (IL-6, IL-8, IL-17) and cognitive scores in either group.
View Article and Find Full Text PDF

Aim: We aimed to assess the service user's acceptability, feasibility, and attitude toward telemedicine practice and compare it with in-person consultation in substance use disorder (SUD).

Materials And Methods: We recruited 15 adult patients with SUD who accessed both telemedicine and in-person care. We conducted in-depth interviews on awareness and access, facilitators and barriers, treatment satisfaction, and therapeutic relationship in the telemedicine context.

View Article and Find Full Text PDF

Background: The opioid receptors in the central nervous system and immune system contribute to its reinforcing effect. Xenobiotics-associated molecular pattern of opioids interacts with Toll-like receptor-4 (TLR-4) on the glial cell surface and increases dopaminergic activity in the nucleus accumbens in preclinical studies. We wanted to examine whether treatment with buprenorphine-naloxone (BNX) might be associated with changes in immunological markers in individuals with opioid dependence (OD).

View Article and Find Full Text PDF

Objective: Buprenorphine (BUP) effectively suppresses non-prescription opioid use and increases treatment retention in opioid use disorder (OUD). However, short prescription length may interfere with treatment retention and recovery. We wanted to examine whether the outcomes of BUP treatment differ in high (HPL up to 4 wk) and low-prescription (LPL 1-2 wk) length groups.

View Article and Find Full Text PDF

We aimed to examine whether treatment retention, abstinence, and adherence to buprenorphine-naloxone (BNX) differ among individuals with opioid dependence (OD) across three common categories of opioids- heroin, opium, and low-potency pharmaceutical. In a retrospective cohort study, we analyzed outpatient treatment records from March 2020 through February 2022. Opioid category was determined by lifetime and current opioid use.

View Article and Find Full Text PDF
Article Synopsis
  • Arsenic is a global public health risk, contaminating groundwater and crops, leading to cognitive impairments even at low exposure levels, especially in young people.
  • This study analyzed data from 1,014 participants aged 6 to 23 to explore how low-level arsenic exposure affects executive function, brain structure, and connectivity using advanced neuropsychological and imaging techniques.
  • Results indicated a significant negative correlation between arsenic exposure and both cognitive function and brain structure, suggesting that alterations in executive function may be partly influenced by changes in gray matter volume.
View Article and Find Full Text PDF

Introduction: We examined the feasibility and acceptability of digital screening and brief intervention (d-SBI) for alcohol misuse in college students; the effectiveness of d-SBI was our secondary outcome. We also explored the barriers and facilitators of d-SBI.

Methods: The study design is a mixed-methods, pilot, and cluster randomized trial.

View Article and Find Full Text PDF

Background: Hepatitis C virus (HCV) infection is commonly comorbid with opioid dependence (OD). We wanted to compare the neurocognitive functions of OD subjects with or without HCV [HCV (+), HCV (-)] and healthy controls (HC).

Methods: We recruited 40 adult subjects (age 18-55 years) in each group.

View Article and Find Full Text PDF

Background: Substance use in workplace leads to adverse effects both on the employees and on the workplace. Existing research focuses on alcohol-related harm, while workplace use of other substances has been neglected. There are no randomized controlled studies of brief interventions in Indian hospital settings.

View Article and Find Full Text PDF